Diligence memo · auto-generated · as of July 2, 2026
Biocogniv Inc.
Biocogniv Inc. looks over-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Biocogniv Inc. operates in Other, based in BURLINGTON, VT, USA.
Sub-sector tags: Healthcare.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
Capital & rounds (filed)filed
Biocogniv Inc. has raised $11M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $11M on 2023-10-04.
Most recent recorded round closed around 2023-10-04.
Valuation (modeled)modeled
Provath models Biocogniv Inc. at approximately $61M (range $15M–$157M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.57× the median modeled value of Series A Other companies in 2022–2024 (1135 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 2.7 yr ago; this sector typically re-raises about every 11 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 78% of Other peers (25015 compared).
Modeled value ranks above 75% of those peers.
Closest niche peers: Ness Well, Inc., Quantori, Inc., Qquv Investments 5, Llc, Applause Network TV, Inc., Trustworthy Co.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
Modeled above niche peers — valuation risk on entry.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.